Revvity Inc (RVTY)

Industry Diagnostics & Research
This stock can be held in an Investment ISA and an Investment Account
Sell

$94.30

Buy

$97.90

arrow-down$-0.02 (-0.02%)

Prices updated at 19 Dec 2025, 23:07 EST
| Prices minimum 15 mins delay
|
Prices in USD
PerkinElmer Inc is a diagnostics company that provides instruments, consumables, and services to biomedical, chemical and to general industrial markets. It operates in two segments namely Discovery and Analytical Solutions and Diagnostics.
S&P 500
arrow-up0.88%
NYSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.

Most recent dividend payment

0.070
Cash Dividend
16 Jan 2026
23 Oct 2025
16 Jan 2026
06 Feb 2026

Total dividend yield

Dividend history and forecast data table

YearDividend per shareDividend growth (%)
20250.2800-
20240.2800-
20230.2800-
20220.2800-
20210.2800-
20200.2800-
20190.2800-
20180.2800-
20170.2800-
20160.2800-

Total dividend yield data table

Year
chevron-l-regular
chevron-r-regular
Dividend yield (%)Buyback yield (%)
20250.307.89
20240.251.41
20230.262.92
20220.200.32
20210.140.29
20200.200.04
20190.290.54
20180.360.06
20170.380.05
20160.542.66

Dividend per share

% of earnings paid to shareholders

Dividend per share data table

YearDividend per share
20250.2800
20240.2800
20230.2800
20220.2800
20210.2800
20200.2800
20190.2800
20180.2800
20170.2800
20160.2800

% of earnings paid to shareholders data table

YearPayout ratio (%)
202514.43
202413.40
202316.47
20225.46
20212.79
20207.59
201913.33
201824.56
201711.97
201613.21
Latest Financial Report as of 18 Dec 2025
Dividend amount and dividend per share are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.